Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Comprehensive review of CRISPR-based gene editing: mechanisms, challenges, and applications in cancer therapy
Mohammad Chehelgerdi, Matin Chehelgerdi, Milad Khorramian‐Ghahfarokhi, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 62

Showing 1-25 of 62 citing articles:

tRNA-derived small RNAs in human cancers: roles, mechanisms, and clinical application
Manli Zhou, Xiaoyun He, Jing Zhang, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 18
Bioengineering in Solid-State Fermentation for next sustainable food bioprocessing
Muyideen Olaitan Bamidele, Micheal Bola Bamikale, Eliseo Cárdenas-Hernández, et al.
Next Sustainability (2025) Vol. 6, pp. 100105-100105
Open Access | Times Cited: 3
Current Advances in the Therapeutic Potential of Scutellarin: Novel Applications, Mechanisms, and Future Challenges.
Great Iruoghene Edo, Alice Njolke Mafe, Patrick Othuke Akpoghelie, et al.
Phytomedicine Plus (2025), pp. 100754-100754
Open Access | Times Cited: 2
Leveraging CRISPR gene editing technology to optimize the efficacy, safety and accessibility of CAR T-cell therapy
Tao Lei, Yazhuo Wang, Yuchen Zhang, et al.
Leukemia (2024)
Open Access | Times Cited: 11
Biotechnological Tools Boost the Functional Diversity of DNA-based Data Storage Systems
Xiaoyuan Xu, Wen Wang, Zhi Ping
Computational and Structural Biotechnology Journal (2025) Vol. 27, pp. 624-630
Open Access | Times Cited: 1
Optimizing CRISPR/Cas9 precision: Mitigating off-target effects for safe integration with photodynamic and stem cell therapies in cancer treatment
J. P. Jose Merlin, Heidi Abrahamse
Biomedicine & Pharmacotherapy (2024) Vol. 180, pp. 117516-117516
Open Access | Times Cited: 7
Correction: Comprehensive review of CRISPR‑based gene editing: mechanisms, challenges, and applications in cancer therapy
Mohammad Chehelgerdi, Matin Chehelgerdi, Milad Khorramian‐Ghahfarokhi, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 6
Epigenetic deregulation in breast cancer microenvironment: Implications for tumor progression and therapeutic strategies
Lenka Trnkova, Verona Buociková, Michal Mego, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 174, pp. 116559-116559
Open Access | Times Cited: 6
Immunometabolic reprogramming of macrophages with inhalable CRISPR/Cas9 nanotherapeutics for acute lung injury intervention
Wanling Huang, Gaohong Fu, Yangeng Wang, et al.
Acta Biomaterialia (2024) Vol. 181, pp. 308-316
Closed Access | Times Cited: 5
CAR products from novel sources: a new avenue for the breakthrough in cancer immunotherapy
Jiawen Huang, Qian Yang, Wen Wang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 5
Application of CRISPR-Cas9 technology in the treatment of Triple Negative Breast Cancer
M. Wei, Yinan Wu
Theoretical and Natural Science (2025) Vol. 75, Iss. 1, pp. 115-125
Closed Access
Exosome-mediated CRISPR/Cas delivery: A cutting-edge frontier in cancer gene therapy
Bhavanisha Rithiga S, Rajib Dhar, Arikketh Devi
Gene (2025), pp. 149296-149296
Closed Access
MicroRNAs as behind-the-scenes molecules in breast cancer metastasis and their therapeutic role through novel microRNA-based delivery strategies
Mohamed J. Saadh, Ashok Kumar Bishoyi, Suhas Ballal, et al.
Gene (2025), pp. 149272-149272
Closed Access
“Lost in translation?” Animal research in the era of precision medicine
Hamideh Mahdiani, Norbert W. Paul
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access
Basic Science, New Target Investigation, and Research in Childhood Cancer
Hafeez Abdelhafeez, Victor M. Santana
(2025), pp. 1-6
Closed Access
Frontiers in superbug management: innovating approaches to combat antimicrobial resistance
Priyanka Chambial, Neelam Thakur, Prudhvi Lal Bhukya, et al.
Archives of Microbiology (2025) Vol. 207, Iss. 3
Closed Access
Towards understanding cancer dormancy over strategic hitching up mechanisms to technologies
Sumin Yang, Jieun Seo, Jeong‐Hyeon Choi, et al.
Molecular Cancer (2025) Vol. 24, Iss. 1
Open Access
Nanotechnology in Gene Editing: Pioneering CRISPR‐Cas Delivery Systems to Tackle Antibiotic Resistance
Sahar Gholamian, Pooya Baghaee, Mohammad Doroudian
Advanced Therapeutics (2025)
Closed Access
Unlocking Ectoine’s Postbiotic Therapeutic Promise: Mechanisms, Applications, and Future Directions
Liu Xingrong, Babbiker Mohammed Taher Gorish, Majjid A. Qaria, et al.
Probiotics and Antimicrobial Proteins (2025)
Closed Access
Investigating the Anticancer Activity of Novel 1,2,4-Oxadiazole-Linked 1,2,3-Triazole Moieties via EGFR/pI3K/mTOR Cascade Down-Regulation
Mohammed Salah Ayoup, Mariam Ghanem, Hamida Abdel‐Hamid, et al.
Polycyclic aromatic compounds (2025), pp. 1-20
Closed Access
Heterozygous GAA knockout is nonconsequential on metabolism and the spatial liver transcriptome in high‐fat diet‐induced obese and prediabetic mice
Chad M. McCall, Melina Cristina Mancini, Jarosław Staszkiewicz, et al.
Physiological Reports (2025) Vol. 13, Iss. 6
Open Access
Lymphoblastoid and Jurkat cell lines are useful surrogate in developing a CRISPR-Cas9 method to correct leukocyte adhesion deficiency genomic defect
A. Ramadan, Noureddine Ben Khalaf, Khaled Trabelsi, et al.
Frontiers in Bioengineering and Biotechnology (2025) Vol. 13
Open Access
Unveiling the future of cancer stem cell therapy: a narrative exploration of emerging innovations
Joseph Nhyira Obisi, Abike Ndidiamaka Josephine Abimbola, Oluwasegun Adesina Babaleye, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
Geographic and Viral Etiology Patterns of TERT Promoter and CTNNB1 Exon 3 Mutations in Hepatocellular Carcinoma: A Comprehensive Review
Mariana Terra, Thaís Barbosa Ferreira Sant’Anna, José J. Barros, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 7, pp. 2889-2889
Open Access
CRISPR/Cas technologies for cancer drug discovery and treatment
Kevin Chang Wang, Thomas M Zheng, Basil P. Hubbard
Trends in Pharmacological Sciences (2025)
Closed Access
Page 1 - Next Page

Scroll to top